Valneva SE (VALN) Cost of Revenue (2021 - 2026)

Valneva SE (VALN) posted quarterly Cost of Revenue of $29.8 million for Q1 2026, up 13.61% year-on-year from $26.2 million in Q1 2025, and down 27.42% on a QoQ basis from $41.0 million in Q4 2025.

Valneva SE (VALN) Cost of Revenue (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Cost of Revenue for 6 consecutive years, with $29.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Cost of Revenue rose 13.61% year-over-year to $29.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.5 million (up 10.92% YoY) and the FY2025 annual result came in at $121.9 million, up 8.73% from the prior year.
  • Cost of Revenue eased to $29.8 million in Q1 2026 per VALN's latest filing, from $41.0 million in the prior quarter.
  • Over the last five years, Cost of Revenue for VALN reached as high as $179.4 million in Q2 2022 and fell as low as $15.8 million in Q1 2022.
  • A 5-year average of $44.0 million and a median of $29.2 million in 2024 frame the typical range for Cost of Revenue.
  • Annual changes were most pronounced in 2022 — Cost of Revenue soared 683.08% — and 2023, when it plunged 78.84%.
  • Year by year, Cost of Revenue stood at $138.5 million in 2022, then sank by 78.59% to $29.7 million in 2023, then gained by 4.48% to $31.0 million in 2024, then jumped by 32.46% to $41.0 million in 2025, then decreased by 27.42% to $29.8 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $29.8 million, $41.0 million, and $27.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 167.22 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 392.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 296.00 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 145.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Valneva SE 839.21 Mn 719.43 Mn 5.38 Mn 29.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.79 Mn
Mar 31, 2026 29.79 Mn
Dec 31, 2025 41.05 Mn
Dec 31, 2025 41.05 Mn
Sep 30, 2025 27.20 Mn
Sep 30, 2025 27.20 Mn
Jun 30, 2025 27.45 Mn
Jun 30, 2025 27.45 Mn
Mar 31, 2025 26.22 Mn
Mar 31, 2025 26.22 Mn
Dec 31, 2024 30.99 Mn
Dec 31, 2024 30.99 Mn
Sep 30, 2024 29.22 Mn
Sep 30, 2024 29.22 Mn
Jun 30, 2024 26.71 Mn
Jun 30, 2024 26.71 Mn
Mar 31, 2024 25.22 Mn
Mar 31, 2024 25.22 Mn
Dec 31, 2023 29.66 Mn
Dec 31, 2023 29.66 Mn